IOVA Iovance Biotherapeutics, Inc. - Common Stock
$7,62
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 6, 2026
52 Haftlık Aralık
$2–$8
98% of range
Analist Derecelendirmesi
BUY
15 analysts
Fiyat Hedefi
$9
+21% upside
P/E (TTM)
-7.0
ROE
-56.0%
Net Kâr Marjı
-148.4%
Iovance Biotherapeutics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Iovance Biotherapeutics, Inc. is a biopharmaceutical based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
Devamını oku
Iovance Biotherapeutics, Inc. is a biopharmaceutical based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte (TIL) therapies against cancer.
## History
The company was founded in 2007 as Genesis Biopharma. In 2013, Lion merged with Genesis Biopharma аnd became Lion Bio Pharma, which was then rebranded to Iovance in 2017.
In 2024, the US FDA gave accelerated approval to Lifileucel, marketed under the brand name Amtagvi, the company's tumor-infiltrating lymphocyte drug for the treatment of unresectable or metastatic melanoma.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
IOVA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$7.62
Piyasa Değeri
$3.14B
P/E (TTM)
-7.0
EPS (TTM)
$-1.09
Gelir (TTM)
$264M
Temettü Verimi
—
ROE
-56.0%
D/E Borç/Özsermaye
0.0
52 Haftlık Aralık
$2 – $8
IOVA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$264M
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$-1.09
2019-12-31
→
2025-12-31
Serbest Nakit Akışı
$-336M
2016-12-31
→
2025-12-31
Marjlar
-148.4%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
IOVA
Akran Ortalaması
P/E (TTM)
-7.0
—
P/S (TTM) (F/S (TTM))
11.9
18.3
P/B (F/D)
4.5
3.3
EV / EBITDA
-7.3
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-9.3
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
IOVA
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-153.1%
—
Net Profit Margin (Net Kâr Marjı)
-148.4%
-180.4%
ROA
-42.9%
-36.2%
ROE
-56.0%
-43.7%
ROIC
-57.4%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
IOVA
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.0
—
Current Ratio (Cari Oran)
3.2
9.7
Quick Ratio (Cari Oran)
2.7
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
IOVA
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
60.6%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
IOVA
Akran Ortalaması
IOVA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
15 analist
- Güçlü Al 3 20,0%
- Al 9 60,0%
- Tut 3 20,0%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
9 analist · 2026-08-19
Medyan
$9.00
Şimdi
$7.62
Düşük
$4.00
Yüksek
$14.00
Medyan hedef
$9.00
+18,2%
Ortalama hedef
$9.22
+21,1%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.03%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.11 | $-0.13 | 0.02% |
| 31 Mart 2026 | $-0.19 | $-0.15 | -0.04% |
| 31 Aralık 2025 | $-0.18 | $-0.18 | -0.00% |
| 30 Eylül 2025 | $-0.25 | $-0.26 | 0.01% |
| 30 Haziran 2025 | $-0.33 | $-0.29 | -0.04% |
| 31 Mart 2025 | $-0.36 | $-0.24 | -0.12% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| VKTX | $4.04B | -11.0 | — | — | -47.3% | — |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $264M | $164M | $1M | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $173M | $93M | $1M | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $300M | $276M | $333M | $295M | $259M | $202M | $166M | $100M | $72M | $27M | $15M | $4M | |
| SG&A Expense | $152M | $152M | $106M | $104M | $84M | $60M | $41M | $28M | $21M | $27M | $12M | $8M | |
| Operating Expenses | $667M | $559M | $462M | $399M | $343M | $262M | $207M | $128M | $93M | $54M | $28M | $12M | |
| Operating Income | $-403M | $-395M | $-461M | $-399M | $-343M | $-262M | $-207M | $-128M | $-93M | $-54M | $-28M | $-12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $-5.7K | |
| Interest Income | $10M | $20M | $13M | $3M | $451.0K | $2M | $9M | $5M | $813.0K | $745.0K | $200.0K | $6.0K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $200.0K | $6.0K | |
| Pretax Income | $-393M | $-375M | $-448M | $-396M | $-342M | · | · | · | · | · | · | · | |
| Income Tax | $-2M | $-3M | $-3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-391M | $-372M | $-444M | $-396M | $-342M | $-260M | $-198M | $-124M | $-92M | $-53M | $-28M | $-12M | |
| EPS (Basic) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · | |
| EPS (Diluted) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | · | · | · | · | · | |
| Shares (Basic) | 357,345 | 289,877 | 235,131 | 159,259 | 153,406 | 138,301 | 124,336 | · | · | · | · | · | |
| Shares (Diluted) | 357,345 | 289,877 | 235,131 | 159,259 | 153,406 | 138,301 | 124,336 | · | · | · | · | · | |
| EBITDA | $-390M | $-383M | $-449M | $-390M | $-340M | $-261M | $-206M | $-128M | $-93M | $-54M | $-28M | · |
Bilanço 28
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $163M | $116M | $115M | $232M | $78M | $67M | $14M | $82M | $145M | $107M | $34M | $45M | |
| Short-term Investments | $134M | $208M | $165M | $240M | $426M | $562M | $293M | $386M | $0 | $60M | $70M | $0 | |
| Receivables | $82M | $69M | $151.0K | · | · | · | · | · | · | · | · | · | |
| Inventory | $52M | $52M | $10M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $12M | $12M | $17M | $7M | $4M | $7M | $9M | $7M | $4M | $3M | $277.0K | $66.0K | |
| Current Assets | $443M | $457M | $308M | $479M | $508M | $636M | $316M | $475M | $149M | $170M | $104M | $45M | |
| PP&E (Net) | $131M | $109M | $114M | $105M | $101M | $59M | $9M | $3M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $180M | $145M | $142M | $122M | $110M | $65M | $13M | $7M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $49M | $36M | $28M | $17M | $9M | $6M | $4M | $4M | $3M | $2M | $1M | $104.0K | |
| Intangibles | $279M | $282M | $229M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $369.0K | $270.0K | $189.0K | $2M | $13M | $3M | $3M | $4M | $0 | · | · | |
| Total Assets | $913M | $910M | $780M | $664M | $777M | $768M | $345M | $481M | $155M | $172M | $106M | $47M | |
| Accounts Payable | $22M | $28M | $33M | $27M | $27M | $14M | $16M | $3M | $1M | $863.0K | $958.0K | $1M | |
| Accrued Liabilities | $111M | $82M | $69M | $52M | $57M | $35M | $16M | $12M | $8M | $4M | $672.0K | $328.0K | |
| Short-term Debt | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $138M | $122M | $110M | $91M | $89M | $55M | $39M | $14M | $10M | $5M | $2M | $2M | |
| Capital Leases | $44M | $44M | $67M | $72M | $65M | $45M | $4M | $0 | · | · | · | · | |
| Deferred Tax | $32M | $32M | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $12M | $2M | $230.0K | · | · | · | · | |
| Total Liabilities | $215M | $200M | $196M | $164M | $156M | $112M | $46M | $15M | $10M | · | · | · | |
| Total Debt | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $17.0K | $13.0K | $11.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $3.46B | $3.10B | $2.59B | $2.07B | $1.79B | $1.49B | $869M | $839M | $395M | $324M | $208M | $121M | |
| Retained Earnings | $-2.78B | $-2.38B | $-2.01B | $-1.57B | $-1.17B | $-830M | $-571M | $-373M | $-249M | $-157M | $-104M | $-77M | |
| AOCI | $16M | $-1M | $3M | $-902.0K | $-601.0K | $19.0K | $220.0K | $-42.0K | $0 | $29.0K | $48.0K | $0 | |
| Stockholders' Equity | $699M | $710M | $585M | $500M | $622M | $656M | $299M | $466M | $145M | $167M | $104M | $45M | |
| Liabilities + Equity | $913M | $910M | $780M | $664M | $777M | $768M | $345M | $481M | $155M | $172M | $106M | $47M | |
| Shares Outstanding | 411,938,061 | 305,252,194 | 256,135,715 | 187,812,072 | 157,004,742 | 147,874,917 | 126,411,808 | 123,415,576 | 73,164,914 | 62,248,074 | 48,547,720 | 33,750,188 |
Nakit Akışı 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $11M | $12M | $9M | $3M | $1M | $1M | $956.0K | $952.0K | $978.0K | $999.0K | $88.0K | |
| Stock-based Comp | $62M | $110M | $63M | $84M | $70M | $41M | $24M | $20M | $12M | $19M | $9M | $4M | |
| Deferred Tax | $-2M | $-3M | $-3M | · | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $23M | $26M | $10M | $0 | · | · | · | · | · | · | · | · | |
| Restructuring | $5M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $16M | $-100M | $12M | $10M | $41M | $12M | $13M | · | · | · | · | · | |
| Operating Cash Flow | $-302M | $-353M | $-362M | $-293M | $-228M | $-205M | $-159M | $-101M | $-79M | $-33M | $-18M | $-9M | |
| CapEx | $34M | $11M | $22M | $20M | $38M | $47M | $7M | $1M | $1M | $2M | $1M | $2M | |
| Investing Cash Flow | $47M | $-96M | $-155M | $256M | $132.0K | $-318M | $90M | $-386M | $59M | $9M | $-71M | · | |
| Debt Issued | · | · | · | · | $1M | · | · | · | · | · | · | · | |
| Net Debt Issued | · | · | · | · | $1M | · | · | · | · | · | · | · | |
| Stock Issued | $306M | $397M | $463M | $190M | $203M | $567M | · | $399M | $54M | $96M | $68M | $32M | |
| Net Stock Activity | $306M | $397M | $463M | $190M | $203M | $567M | · | $399M | $54M | $96M | $68M | · | |
| Financing Cash Flow | $301M | $391M | $463M | $190M | $239M | $576M | $6M | $424M | $59M | $97M | $78M | · | |
| Net Change in Cash | $47M | $-59M | $-57M | $154M | $11M | · | · | $-63M | $39M | $73M | $-11M | $25M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-336M | $-364M | $-384M | $-313M | $-266M | $-252M | $-166M | $-102M | $-80M | $-34M | $-20M | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -153.1% | -240.9% | -38735.0% | · | · | · | · | · | · | · | · | · | |
| Net Margin | -148.4% | -226.8% | -37345.4% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | -149.2% | -228.6% | -37638.0% | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -148.2% | -233.6% | -37762.1% | · | · | · | · | · | · | · | · | · | |
| ROA | -42.9% | -44.0% | -61.5% | -54.9% | -44.3% | -46.6% | -47.9% | -38.9% | -56.3% | -38.1% | -36.4% | · | |
| ROE | -56.0% | -50.2% | -70.6% | -88.6% | -51.9% | -37.9% | -60.4% | -34.3% | -58.9% | -39.0% | -37.2% | · | |
| ROIC | -57.4% | -55.2% | -78.2% | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.7 | 2.8 | 5.2 | 5.7 | 11.6 | 8.1 | 33.0 | 15.1 | 34.1 | 63.8 | · | |
| Quick Ratio | 2.7 | 3.2 | 2.5 | 5.2 | 5.7 | 11.5 | 7.9 | 32.5 | 14.7 | 33.5 | 51.4 | · | |
| Debt / Equity | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.0 | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Inventory Turnover | 3.4 | 4.0 | 2.1 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 3.5 | 4.7 | 15.7 | · | · | · | · | · | · | · | · | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 60.6% | 13699.0% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $264M | $164M | $1M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-391M | $-372M | $-444M | $-396M | $-342M | $-260M | $-198M | $-124M | $-92M | $-53M | $-28M | $-12M | |
| Market Cap | $1.12B | $2.26B | $2.08B | $1.20B | $3.00B | $6.81B | $3.50B | $1.09B | $585M | $433M | $375M | · | |
| Enterprise Value | $829M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -2.5 | -5.8 | -4.3 | -2.6 | -8.6 | -24.7 | -17.4 | · | · | · | · | · | |
| P/S | 4.3 | 13.8 | 1751.4 | · | · | · | · | · | · | · | · | · | |
| P/B | 1.6 | 3.2 | 3.6 | 2.4 | 4.8 | 10.4 | 11.7 | 2.3 | 4.0 | 2.6 | 3.6 | · | |
| P / Tangible Book | 2.7 | 5.3 | 5.9 | 2.4 | 4.8 | 10.4 | · | · | · | · | · | · | |
| P / Cash Flow | -3.7 | -6.4 | -5.8 | -4.1 | -13.1 | -33.2 | -22.0 | -10.8 | -7.4 | -13.2 | -20.4 | · | |
| P / FCF | -3.3 | -6.2 | -5.4 | -3.8 | -11.3 | -27.1 | -21.1 | -10.7 | -7.3 | -12.7 | -19.2 | · | |
| EV / EBITDA | -2.1 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -2.5 | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 3.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -39.9% | -17.3% | -23.2% | -39.0% | -11.7% | -4.0% | -5.7% | · | · | · | · | · |
Gelir Tablosu 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $99M | $71M | $87M | $67M | $60M | $49M | $74M | $59M | $31M | $715.0K | $482.0K | $469.0K | $238.0K | · | · | · | |
| Cost of Revenue | $44M | $42M | $28M | $38M | $49M | $43M | $23M | $32M | $31M | $7M | $-5M | $4M | $2M | · | · | · | |
| R&D Expense | $59M | $62M | $69M | $75M | $78M | $76M | $67M | $67M | $62M | $80M | $77M | $88M | $86M | $83M | $81M | $73M | |
| SG&A Expense | $39M | $39M | $36M | $35M | $38M | $44M | $42M | $39M | $40M | $31M | $29M | $27M | $22M | $28M | $26M | $28M | |
| Operating Expenses | $151M | $152M | $160M | $162M | $174M | $171M | $160M | $148M | $133M | $118M | $122M | $119M | $110M | $111M | $107M | $100M | |
| Operating Income | $-52M | $-81M | $-73M | $-95M | $-114M | $-121M | $-87M | $-89M | $-102M | $-118M | $-121M | $-118M | $-110M | $-111M | $-107M | $-100M | |
| Interest Income | $3M | $1M | $2M | $1M | $4M | $3M | $10M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $777.0K | |
| Pretax Income | $-49M | $-80M | $-72M | $-94M | $-110M | $-118M | $-77M | $-85M | $-99M | $-114M | $-118M | $-115M | $-107M | $-107M | $-105M | $-100M | |
| Income Tax | $-1M | $-665.0K | $184.0K | $-2M | $2M | $-2M | $2M | $-2M | $-1M | $-1M | $-2M | $-1M | $-477.0K | $0 | · | · | |
| Net Income | $-47M | $-79M | $-72M | $-91M | $-112M | $-116M | $-79M | $-84M | $-97M | $-113M | $-116M | $-114M | $-107M | $-107M | $-105M | $-100M | |
| EPS (Basic) | $-0.11 | $-0.19 | $-0.15 | $-0.25 | $-0.33 | $-0.36 | $-0.24 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.50 | $-0.65 | $-0.63 | |
| EPS (Diluted) | $-0.11 | $-0.19 | · | · | $-0.33 | $-0.36 | $-0.24 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.46 | $-0.47 | $-0.50 | $-0.65 | $-0.63 | |
| Shares (Basic) | 450,189 | 418,511 | -664,071 | 364,037 | 334,511 | 322,868 | -564,429 | 303,269 | 284,817 | 266,220 | -213,929,167 | 245,817 | 224,481 | 213,694,000 | -472,044,741 | 157,817,000 | |
| Shares (Diluted) | 450,189 | 418,511 | · | · | 334,511 | 322,868 | -564,429 | 303,269 | 284,817 | 266,220 | -213,929,167 | 245,817 | 224,481 | 213,694,000 | -472,044,741 | 157,817,000 | |
| EBITDA | $-52M | $-78M | · | $-95M | $-110M | $-118M | · | $-86M | $-99M | $-115M | · | $-115M | $-107M | $-108M | · | $-100M |
Bilanço 27
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $197M | $163M | $158M | $132M | $172M | $116M | $164M | $229M | $134M | $115M | $268M | $230M | $543M | $232M | $118M | |
| Short-term Investments | $187M | $117M | $134M | $143M | $169M | $188M | $208M | $233M | $184M | $222M | · | $94M | $21M | $83M | · | $242M | |
| Receivables | $102M | $82M | $82M | $67M | $60M | $71M | $69M | $56M | $32M | $234.0K | · | · | $33.0K | · | · | · | |
| Inventory | $56M | $58M | $52M | $52M | $50M | $66M | $52M | $39M | $28M | $18M | · | $9M | $10M | · | · | · | |
| Prepaid Expense | $9M | $13M | $12M | $10M | $12M | $16M | $12M | $7M | $10M | $11M | · | $12M | $14M | $11M | · | $10M | |
| Current Assets | $464M | $467M | $443M | $429M | $422M | $513M | $457M | $499M | $482M | $386M | · | $383M | $275M | $638M | · | $370M | |
| PP&E (Net) | $131M | $131M | $131M | $127M | $122M | $112M | $109M | $113M | $111M | $112M | · | $113M | $113M | $110M | · | $101M | |
| PP&E (Gross) | $188M | $184M | $180M | $172M | $165M | $150M | $145M | $149M | $145M | $143M | · | $138M | $135M | $129M | · | $115M | |
| Accum. Depreciation | $56M | $52M | $49M | $45M | $42M | $39M | $36M | $37M | $34M | $31M | · | $25M | $22M | $19M | · | $14M | |
| Intangibles | $264M | $269M | $279M | $285M | $296M | $285M | $282M | $307M | $295M | $294M | · | $224M | $236M | · | · | · | |
| Other Non-current Assets | $6M | $8M | $8M | $9M | $10M | $426.0K | $369.0K | $280.0K | $327.0K | $259.0K | · | $282.0K | $294.0K | $202.0K | · | $596.0K | |
| Total Assets | $916M | $926M | $913M | $905M | $907M | $967M | $910M | $991M | $964M | $870M | · | $852M | $757M | $825M | · | $546M | |
| Accounts Payable | $26M | $37M | $22M | $31M | $32M | $28M | $28M | $32M | $20M | $26M | · | $19M | $31M | $32M | · | $24M | |
| Accrued Liabilities | $78M | $88M | $111M | $87M | $89M | $85M | $82M | $75M | $62M | $46M | · | $61M | $47M | $43M | · | $48M | |
| Short-term Debt | · | $1M | $1M | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $107M | $129M | $138M | $126M | $129M | $123M | $122M | $118M | $94M | $83M | · | $91M | $89M | $87M | · | $79M | |
| Capital Leases | $43M | $44M | $44M | $45M | $45M | $44M | $44M | $66M | $69M | $72M | · | $68M | $69M | $70M | · | $72M | |
| Deferred Tax | $29M | $31M | $32M | $32M | $35M | $32M | $32M | $32M | $32M | $33M | · | $18M | $20M | · | · | · | |
| Total Liabilities | $179M | $204M | $215M | $203M | $209M | $199M | $200M | $218M | $196M | $190M | · | $178M | $179M | $158M | · | $152M | |
| Total Debt | · | $1M | · | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $19.0K | $18.0K | $17.0K | $16.0K | $14.0K | $14.0K | $13.0K | $13.0K | $12.0K | $12.0K | · | $11.0K | $9.0K | $9.0K | · | $7.0K | |
| Paid-in Capital | $3.62B | $3.56B | $3.46B | $3.39B | $3.29B | $3.26B | $3.10B | $3.06B | $2.99B | $2.81B | · | $2.58B | $2.36B | $2.34B | · | $1.86B | |
| Retained Earnings | $-2.90B | $-2.85B | $-2.78B | $-2.70B | $-2.61B | $-2.50B | $-2.38B | $-2.31B | $-2.22B | $-2.13B | · | $-1.90B | $-1.78B | $-1.68B | · | $-1.46B | |
| AOCI | $13M | $13M | $16M | $16M | $21M | $6M | $-1M | $16M | $526.0K | $116.0K | · | $-9M | $325.0K | $-126.0K | · | $-2M | |
| Stockholders' Equity | $736M | $722M | $699M | $702M | $698M | $768M | $710M | $773M | $769M | $680M | $585M | $674M | $579M | $667M | $500M | $394M | |
| Liabilities + Equity | $916M | $926M | $913M | $905M | $907M | $967M | $910M | $991M | $964M | $870M | · | $852M | $757M | $825M | · | $546M | |
| Shares Outstanding | 452,971,016 | 438,106,537 | 411,938,061 | 385,461,728 | 341,919,364 | 333,934,387 | 305,252,194 | 304,620,470 | 297,305,999 | 279,756,339 | · | 255,833,679 | 224,688,434 | 224,358,979 | · | 157,840,581 |
Nakit Akışı 15
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $3M | $4M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Stock-based Comp | $12M | $11M | $12M | $12M | $15M | $23M | $31M | $31M | $30M | $17M | $14M | $16M | $17M | $16M | $20M | $20M | |
| Deferred Tax | $-1M | $-665.0K | $184.0K | $-2M | $2M | $-2M | $2M | $-2M | $-1M | $-1M | $-2M | $-1M | $-477.0K | $0 | · | $0 | |
| Amort. of Intangibles | $6M | $6M | $6M | $6M | $6M | $5M | $11M | $6M | $6M | $5M | $4M | $4M | $2M | $0 | · | $0 | |
| Restructuring | · | · | $0 | $5M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-6M | · | · | · | $-11M | · | · | · | $-28M | · | · | · | $-11M | · | · | |
| Operating Cash Flow | $-61M | $-72M | $-53M | $-79M | $-67M | $-104M | $-73M | $-59M | $-98M | $-122M | $-84M | $-84M | $-94M | $-100M | $-78M | $-64M | |
| CapEx | $5M | $7M | $9M | $11M | $7M | $6M | $4M | $2M | $442.0K | $4M | $4M | $4M | $10M | $6M | $3M | $1M | |
| Investing Cash Flow | $-74M | $11M | $775.0K | $17M | $14M | $16M | $24M | $-49M | $40M | $-112M | $-73M | $-79M | $-157M | $153M | $461.0K | $74M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Issued | $50M | $99M | $56M | $89M | $13M | $149M | $0 | $48M | $152M | $198M | $1.0K | $203M | $0 | $260M | $190M | $0 | |
| Net Stock Activity | · | $99M | · | · | · | $149M | · | · | · | $198M | · | · | · | $260M | · | · | |
| Financing Cash Flow | $49M | $94M | $56M | $88M | $13M | $143M | $2M | $42M | $153M | $194M | $962.0K | $203M | $1M | $258M | $191M | $225.0K | |
| Net Change in Cash | $-86M | $33M | $5M | $26M | $-40M | $56M | $-48M | $-65M | $94M | $-41M | $-153M | $38M | $-253M | $312M | $113M | $10M | |
| Free Cash Flow | · | $-79M | · | · | · | $-110M | · | · | · | $-126M | · | · | · | $-105M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -52.3% | -113.5% | · | -140.7% | -189.8% | -245.8% | · | -152.1% | -327.6% | -16464.6% | · | -25236.9% | -46254.6% | · | · | · | |
| Net Margin | -47.6% | -110.7% | · | -135.3% | -186.2% | -235.5% | · | -142.7% | -312.2% | -15800.8% | · | -24255.9% | -44759.7% | · | · | · | |
| Pretax Margin | -49.0% | -111.6% | · | -138.8% | -182.9% | -239.2% | · | -145.3% | -316.8% | -15997.8% | · | -24520.9% | -44960.1% | · | · | · | |
| EBITDA Margin | -52.3% | -109.5% | · | -140.7% | -184.1% | -240.1% | · | -147.0% | -318.0% | -16048.1% | · | -24618.5% | -45036.1% | · | · | · | |
| ROA | -5.2% | -8.3% | · | -9.6% | -11.9% | -12.7% | · | -9.1% | -11.3% | -13.3% | · | -16.3% | -15.6% | -14.1% | · | -14.5% | |
| ROE | -6.6% | -10.6% | · | -12.4% | -15.2% | -16.1% | · | -11.5% | -14.4% | -16.8% | · | -21.3% | -20.3% | -17.6% | · | -18.2% | |
| ROIC | -6.9% | -11.1% | · | -13.2% | -16.6% | -15.5% | · | -11.3% | -13.1% | -17.1% | · | -17.4% | -18.9% | · | · | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 3.6 | · | 3.4 | 3.3 | 4.2 | · | 4.2 | 5.2 | 4.6 | · | 4.2 | 3.1 | 7.3 | · | 4.7 | |
| Quick Ratio | 3.7 | 3.1 | · | 2.9 | 2.8 | 3.5 | · | 3.8 | 4.7 | 4.3 | · | 4.0 | 2.8 | 7.2 | · | 4.5 | |
| Debt / Equity | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 0.8 | 0.7 | · | 0.9 | 1.5 | 1.2 | · | 1.7 | 1.7 | 0.8 | · | 0.9 | 0.4 | · | · | · | |
| Receivables Turnover | 1.2 | 0.9 | · | 1.1 | 1.3 | 1.4 | · | 2.1 | 2.0 | 6.1 | · | · | 14.4 | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $298M | $248M | · | $235M | $199M | $140M | · | $91M | $33M | · | · | · | · | $0 | · | $0 | |
| Net Income TTM | $-329M | $-398M | · | $-403M | $-408M | $-410M | · | $-407M | $-430M | $-441M | · | $-427M | $-413M | $-398M | · | $-377M | |
| Market Cap | $1.88B | $1.54B | · | $836M | $588M | $1.11B | · | $2.86B | $2.38B | $4.15B | · | $1.16B | $1.58B | $1.37B | · | $1.51B | |
| Enterprise Value | · | $1.23B | · | $537M | $288M | $753M | · | · | · | · | · | · | · | · | · | · | |
| P/E | · | · | · | -1.7 | -1.3 | -2.4 | · | -6.3 | -4.7 | -8.0 | · | -2.2 | -3.2 | -2.6 | · | -4.0 | |
| P/S | 6.3 | 6.2 | · | 3.6 | 3.0 | 8.0 | · | 31.5 | 73.3 | · | · | · | · | · | · | · | |
| P/B | 2.6 | 2.1 | · | 1.2 | 0.8 | 1.4 | · | 3.7 | 3.1 | 6.1 | · | 1.7 | 2.7 | 2.1 | · | 3.8 | |
| P / Tangible Book | 4.0 | 3.4 | · | 2.0 | 1.5 | 2.3 | · | 6.1 | 5.0 | 10.7 | · | 2.6 | 4.6 | 2.1 | · | 3.8 | |
| P / Cash Flow | · | -21.3 | · | · | · | -10.7 | · | · | · | -33.9 | · | · | · | -13.7 | · | · | |
| P / FCF | · | -19.5 | · | · | · | -10.1 | · | · | · | -32.8 | · | · | · | -13.0 | · | · | |
| EV / EBITDA | · | -15.7 | · | -5.7 | -2.6 | -6.4 | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | -15.6 | · | · | · | -6.9 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | 4.9 | · | 2.3 | 1.4 | 5.4 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | · | · | -60.4% | -76.2% | -42.0% | · | -16.0% | -21.1% | -12.5% | · | -45.3% | -31.7% | -38.3% | · | -24.9% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $264M | $164M | $1M | — | — |
| Faaliyet Kâr Marjı % | -153.1% | -240.9% | -38735.0% | — | — |
| Net Gelir | $-391M | $-372M | $-444M | $-396M | $-342M |
| Seyreltilmiş Hisse Başı Kâr | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.0 | — | — | — | — |
| Cari Oran | 3.2 | 3.7 | 2.8 | 5.2 | 5.7 |
| Cari Oran | 2.7 | 3.2 | 2.5 | 5.2 | 5.7 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-336M | $-364M | $-384M | $-313M | $-266M |
Son Haberler Bu şirketten bahseden son manşetler
- Iovance Biotherapeutics (IOVA) Yıldızlarla Dolu 2. Çeyrek Sonrası %43 Yükseldi. Sırada Ne Var?
- Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Small-Cap Stocks to Buy Now?
- Chardan, Iovance'ın (IOVA) Hedef Fiyatını Düşürdü, Al Tavsiyesini Korudu
- Iovance Biotherapeutics Q1 Kazanç Konuşması Özetleri
- Analist Görüşü, Melanoma İlaçı Amtagvi'nin ABD Piyasasına Girişine Rampingen Iovance Biotherapeutics (IOVA) Hakkında Güçlü Kalıyor
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 317 dosya · $915.1M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 49 (-21 önceki Ç'ye göre) | 35 (+1 önceki Ç'ye göre) | 124 (+7 önceki Ç'ye göre) | 62 (-4 önceki Ç'ye göre) | +13.6M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| MHR FUND MANAGEMENT LLC | $120.503.148 | 28.967.103 | 13,17% | Hisse senetleri |
| STATE STREET CORP | $101.829.595 | 24.478.268 | 11,13% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $79.084.500 | 19.010.697 | 8,64% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $75.729.672 | 18.204.248 | 8,28% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $59.858.236 | 14.388.999 | 6,54% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $36.971.836 | 8.885.825 | 4,04% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $35.467.823 | 8.525.919 | 3,88% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $24.866.629 | 5.977.555 | 2,72% | Hisse senetleri |
| Palo Alto Investors LP | $22.032.229 | 5.296.209 | 2,41% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $19.240.719 | 4.625.173 | 2,10% | Hisse senetleri |
| JUPITER ASSET MANAGEMENT LTD | $18.865.933 | 4.535.080 | 2,06% | Hisse senetleri |
| JANE STREET GROUP, LLC | $17.758.903 | 4.268.967 | 1,94% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $13.393.769 | 3.219.656 | 1,46% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.097.216 | 2.667.600 | 1,21% | Alım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.052.038 | 2.656.740 | 1,21% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $10.683.579 | 2.568.168 | 1,17% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $10.578.372 | 2.542.878 | 1,16% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9.953.632 | 2.392.700 | 1,09% | Satım opsiyonu |
| D. E. Shaw & Co., Inc. | $8.915.437 | 2.143.134 | 0,97% | Hisse senetleri |
| CITADEL ADVISORS LLC | $8.756.758 | 2.104.990 | 0,96% | Hisse senetleri |
| Long Focus Capital Management, LLC | $8.736.000 | 2.100.000 | 0,95% | Hisse senetleri |
| Orion Investment Co | $8.624.520 | 2.073.202 | 0,94% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $8.230.950 | 3.015.000 | 0,90% | Hisse senetleri |
| Xcelsior Advisor Partners LLC | $7.421.124 | 1.783.924 | 0,81% | Hisse senetleri |
| Rhenman & Partners Asset Management AB | $7.094.160 | 1.705.327 | 0,78% | Hisse senetleri |
| Knott David M Jr | $6.656.000 | 1.600.000 | 0,73% | Hisse senetleri |
| RICE HALL JAMES & ASSOCIATES, LLC | $6.405.734 | 1.539.840 | 0,70% | Hisse senetleri |
| B Group, Inc. | $6.240.000 | 1.500.000 | 0,68% | Hisse senetleri |
| Invenomic Capital Management LP | $6.167.595 | 1.482.595 | 0,67% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $5.994.285 | 1.440.934 | 0,66% | Hisse senetleri |
| VANGUARD GROUP INC | $5.760.305 | 2.110.002 | 0,63% | Hisse senetleri |
| Woodline Partners LP | $5.671.020 | 1.363.226 | 0,62% | Hisse senetleri |
| FMR LLC | $5.629.570 | 1.353.262 | 0,62% | Hisse senetleri |
| JPMORGAN CHASE & CO | $4.919.364 | 1.168.495 | 0,54% | Hisse senetleri |
| Mirador Capital Partners LP | $4.493.998 | 1.080.288 | 0,49% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $4.391.217 | 1.055.581 | 0,48% | Hisse senetleri |
| SECTOR GAMMA AS | $4.028.819 | 968.466 | 0,44% | Hisse senetleri |
| CITIGROUP INC | $3.574.126 | 859.165 | 0,39% | Hisse senetleri |
| CITADEL ADVISORS LLC | $3.385.824 | 813.900 | 0,37% | Alım opsiyonu |
| BlackRock, Inc. | $3.047.371 | 732.541 | 0,33% | Hisse senetleri |
| JANE STREET GROUP, LLC | $3.037.216 | 730.100 | 0,33% | Alım opsiyonu |
| CITADEL ADVISORS LLC | $2.996.864 | 720.400 | 0,33% | Satım opsiyonu |
| Swiss National Bank | $2.922.633 | 702.556 | 0,32% | Hisse senetleri |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2.862.637 | 688.134 | 0,31% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $2.848.240 | 684.673 | 0,31% | Hisse senetleri |
| QVT Financial LP | $2.822.826 | 678.564 | 0,31% | Hisse senetleri |
| LPL Financial LLC | $2.750.070 | 661.075 | 0,30% | Hisse senetleri |
| 683 Capital Management, LLC | $2.680.288 | 644.300 | 0,29% | Satım opsiyonu |
| RHUMBLINE ADVISERS | $2.471.712 | 594.164 | 0,27% | Hisse senetleri |
| Mariner, LLC | $2.101.647 | 505.190 | 0,23% | Hisse senetleri |
| ALGERT GLOBAL LLC | $1.975.746 | 474.939 | 0,22% | Hisse senetleri |
| CM Management, LLC | $1.872.000 | 450.000 | 0,20% | Hisse senetleri |
| Bank of New York Mellon Corp | $1.855.065 | 445.929 | 0,20% | Hisse senetleri |
| Rafferty Asset Management, LLC | $1.675.981 | 402.880 | 0,18% | Hisse senetleri |
| Raiffeisen Bank International AG | $1.599.800 | 380.000 | 0,17% | Hisse senetleri |
| Cresset Asset Management, LLC | $1.596.550 | 383.786 | 0,17% | Hisse senetleri |
| Balyasny Asset Management L.P. | $1.552.861 | 373.284 | 0,17% | Hisse senetleri |
| CORSAIR CAPITAL MANAGEMENT, L.P. | $1.539.200 | 370.000 | 0,17% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $1.477.850 | 421.040 | 0,16% | Hisse senetleri |
| JANE STREET GROUP, LLC | $1.436.032 | 345.200 | 0,16% | Satım opsiyonu |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $1.420.778 | 404.780 | 0,16% | Hisse senetleri |
| Squarepoint Ops LLC | $1.354.421 | 325.582 | 0,15% | Hisse senetleri |
| Kennondale Capital Management LLC | $1.323.662 | 318.188 | 0,14% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $1.222.994 | 293.989 | 0,13% | Hisse senetleri |
| IEQ CAPITAL, LLC | $1.218.722 | 292.962 | 0,13% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.186.078 | 285.115 | 0,13% | Hisse senetleri |
| Virtus Investment Advisers, LLC | $1.185.683 | 285.020 | 0,13% | Hisse senetleri |
| Creative Planning | $1.171.914 | 281.710 | 0,13% | Hisse senetleri |
| Quadrature Capital Ltd | $1.160.378 | 278.937 | 0,13% | Hisse senetleri |
| MORGAN STANLEY | $1.142.544 | 274.650 | 0,12% | Hisse senetleri |
| ExodusPoint Capital Management, LP | $1.125.925 | 270.655 | 0,12% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.090.532 | 262.147 | 0,12% | Hisse senetleri |
| Man Group plc | $1.052.309 | 252.959 | 0,11% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.036.826 | 295.392 | 0,11% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.025.353 | 246.479 | 0,11% | Hisse senetleri |
| TD Asset Management Inc | $1.019.416 | 245.052 | 0,11% | Hisse senetleri |
| GROUP ONE TRADING LLC | $988.711 | 237.671 | 0,11% | Hisse senetleri |
| MetLife Investment Management, LLC | $965.748 | 232.151 | 0,11% | Hisse senetleri |
| UBS Group AG | $952.890 | 229.060 | 0,10% | Hisse senetleri |
| Baird Financial Group, Inc. | $924.934 | 222.340 | 0,10% | Hisse senetleri |
| Walleye Capital LLC | $923.104 | 221.900 | 0,10% | Alım opsiyonu |
| Vanguard Global Advisers, LLC | $900.228 | 216.401 | 0,10% | Hisse senetleri |
| PROFUND ADVISORS LLC | $849.530 | 204.214 | 0,09% | Hisse senetleri |
| Parametrica Management Ltd | $814.852 | 195.878 | 0,09% | Hisse senetleri |
| Engineers Gate Manager LP | $790.546 | 190.035 | 0,09% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $762.349 | 183.257 | 0,08% | Hisse senetleri |
| Invesco Ltd. | $657.292 | 158.003 | 0,07% | Hisse senetleri |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $646.872 | 155.498 | 0,07% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $635.207 | 152.695 | 0,07% | Hisse senetleri |
| Intellectus Partners, LLC | $631.677 | 151.846 | 0,07% | Hisse senetleri |
| Leonteq Securities AG | $624.000 | 150.000 | 0,07% | Hisse senetleri |
| Soleus Capital Management, L.P. | $624.000 | 150.000 | 0,07% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $607.734 | 146.090 | 0,07% | Hisse senetleri |
| Headlands Technologies LLC | $577.570 | 138.839 | 0,06% | Hisse senetleri |
| Sugar Maple Asset Management, LLC | $561.600 | 135.000 | 0,06% | Hisse senetleri |
| PORTLAND INVESTMENT COUNSEL INC. | $540.800 | 130.000 | 0,06% | Hisse senetleri |
| SIMPLEX TRADING, LLC | $524.605 | 126.107 | 0,06% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $497.977 | 141.672 | 0,05% | Hisse senetleri |
| Police & Firemen's Retirement System of New Jersey | $488.292 | 117.378 | 0,05% | Hisse senetleri |
| BARCLAYS PLC | $482.759 | 116.048 | 0,05% | Hisse senetleri |
Şirket yöneticileri 37 içeriden öğrenenler · 9 yöneticiler · 14 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Frederick G Vogt | Interim CEO & General Counsel | 05 Haziran 2026 M | 562.492 | 0 | 0 | $0 |
| Maria Fardis | President and CEO | 04 Ocak 2021 A | 298.786 | 0 | 0 | $0 |
| Paul Kessler | Chair,CEO, Pres., Pr.Acctg | 24 Temmuz 2013 A | 15.693.215 | 0 | 0 | $0 |
| Jean-Marc Bellemin | Chief Financial Officer | 02 Haziran 2025 M | 60.529 | 0 | 0 | $0 |
| Timothy E Morris | Chief Financial Officer | 04 Mart 2019 A | — | 0 | 0 | $0 |
| Igor Bilinsky | Chief Operating Officer | 05 Haziran 2026 M | 133.920 | 0 | 0 | $0 |
| Raj K. Puri | Chief Regulatory Officer | 16 Haziran 2026 A | 248.114 | 0 | 0 | $0 |
| Finckenstein Friedrich Graf | Chief Medical Officer | 05 Haziran 2026 M | 140.111 | 0 | 0 | $0 |
| Michael Swartzburg | Vice President, Finance (PAO) | 04 Ocak 2021 A | — | 0 | 0 | $0 |
| Iain D. Dukes | Yönetim kurulu üyesi | 16 Haziran 2026 A | 54.000 | 0 | 0 | $0 |
| Athena Countouriotis | Yönetim kurulu üyesi | 16 Haziran 2026 A | — | 0 | 0 | $0 |
| Ryan D Maynard | Yönetim kurulu üyesi | 16 Haziran 2026 A | 7.500 | 0 | 0 | $0 |
| Michael Weiser | Yönetim kurulu üyesi | 16 Haziran 2026 A | 112.632 | 0 | 0 | $0 |
| Wendy L Yarno | Yönetim kurulu üyesi | 13 Haziran 2025 A | — | 0 | 0 | $0 |
| Wayne P. Rothbaum | Yönetim kurulu üyesi | 01 Mart 2024 A | 28.067.333 | 0 | 0 | $0 |
| Merrill A Mcpeak | Yönetim kurulu üyesi | 01 Mart 2024 A | 320.150 | 0 | 0 | $0 |
| Wendy L Dixon | Yönetim kurulu üyesi | 10 Haziran 2022 A | — | 0 | 0 | $0 |
| Ayer Capital Management, LP | Yönetim kurulu üyesi | 22 Mayıs 2013 C | 560.401.150 | 0 | 0 | $0 |
| Martin Schroeder | Yönetim kurulu üyesi | 22 Ağustos 2011 P | 1.000.000 | 0 | 0 | $0 |
| Mark J Ahn | Yönetim kurulu üyesi | 26 Mayıs 2010 A | — | 0 | 0 | $0 |
| Bristol Investment Fund, Ltd. | 10% sahip | 06 Kasım 2014 S | 3.867.863 | 0 | 0 | $0 |
| Hamilton Atlantic | 10% sahip | 31 Mart 2010 J | 0 | 0 | 0 | $0 |
| Daniel Gordon Kirby | — | 10 Ağustos 2026 M | 154.511 | 0 | 0 | $0 |
| Corleen M. Roche | — | 06 Ağustos 2026 M | 28.757 | 0 | 0 | $0 |
| Jay Venkatesan | — | 01 Haziran 2017 A | — | 0 | 0 | $0 |
| Sanford Hillsberg | — | 01 Haziran 2017 A | 100.000 | 0 | 0 | $0 |
| Gregory T Schiffman | — | 14 Kasım 2016 A | — | 0 | 0 | $0 |
| Molly Henderson | — | 10 Haziran 2016 A | — | 0 | 0 | $0 |
| Michael Lotze | — | 28 Mart 2016 A | — | 0 | 0 | $0 |
| James G. Bender | — | 11 Mart 2016 A | 88.726 | 0 | 0 | $0 |
| Elma Hawkins | — | 11 Mart 2016 A | 176.567 | 0 | 0 | $0 |
| Steven A. Fischkoff | — | 04 Şubat 2016 A | — | 0 | 0 | $0 |
| Laszlo Radvanyi | — | 05 Aralık 2014 A | 180.000 | 0 | 0 | $0 |
| Michael D Handelman | — | 05 Aralık 2014 A | — | 0 | 0 | $0 |
| Manish Singh | — | 30 Aralık 2013 A | 2.546.000 | 0 | 0 | $0 |
| Richard Mckilligan | — | 29 Mart 2011 J | 1.220.016 | 0 | 0 | $0 |
| Robert T. Brooke | — | 25 Mart 2011 J | 4.440.008 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 6 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Quogue Capital LLC, Wayne P. Rothbaum ×5 başvurular | 19 Mart 2024 | — | İlk başvuru | — | SEC |
| Açıklanmayan raporlama kişisi | 11 Şubat 2015 | — | İlk başvuru | — | SEC |
| Bristol Investment Fund, Ltd., Bristol Capital, LLC ×4 başvurular | 20 Şubat 2014 | — | İlk başvuru | — | SEC |
| Robert T. Brooke ×2 başvurular | 12 Mayıs 2011 | — | İlk başvuru | — | SEC |
| Hamilton Atlantic | 05 Kasım 2010 | — | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi | 29 Mart 2010 | — | İlk başvuru | M&A / satış | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 49 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 2,44% | 430.167 NS | 30 Nisan 2026 | N-PORT |
| CANC · Tema ETF Trust | 0,65% | 280.048 NS | 31 Mayıs 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,30% | 466.051 NS | 30 Nisan 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,09% | 45.126 NS | 31 Mayıs 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,09% | 6.714 NS | 31 Mayıs 2026 | N-PORT |
| BIB · ProShares Trust | 0,08% | 15.232 NS | 31 Mayıs 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,07% | 452.513 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 1.472.303 NS | 30 Nisan 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 15.876 NS | 31 Mayıs 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 146.249 NS | 30 Nisan 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 1.615.534 NS | 31 Mayıs 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 12.416 NS | 31 Mayıs 2026 | N-PORT |
| TMFE · RBB Fund, Inc. | 0,02% | 3.704 NS | 31 Mayıs 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 140.923 NS | 30 Nisan 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 18.065 NS | 30 Nisan 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 12.558 NS | 31 Mayıs 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 71.148 NS | 30 Nisan 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 12.045 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 315 NS | 31 Mayıs 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 44.207 NS | 30 Nisan 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 125.344 NS | 31 Mayıs 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 146.278 NS | 30 Nisan 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 482.457 NS | 30 Nisan 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 89.379 NS | 31 Mayıs 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 16.834 NS | 30 Nisan 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 128.547 NS | 30 Nisan 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 224.829 NS | 31 Mayıs 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VBR · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 Temmuz 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Temmuz 2026 | Günlük |
| ITOT · iShares Trust | — | — | 22 Temmuz 2026 | Günlük |
| IWV · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IWN · iShares Trust | — | — | 17 Ağustos 2026 | Günlük |
| IWM · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| IBB · iShares Trust | — | — | 18 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 28 Temmuz 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | — | — | 20 Temmuz 2026 | Günlük |
| ISCB · iShares Trust | — | — | 20 Temmuz 2026 | Günlük |
| ISCV · iShares Trust | — | — | 20 Temmuz 2026 | Günlük |
| IDNA · iShares Trust | — | — | 12 Ağustos 2026 | Günlük |
| TECB · iShares Trust | — | — | 21 Temmuz 2026 | Günlük |
| WSML · iShares Trust | — | — | 20 Temmuz 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | 20 Temmuz 2026 | Günlük |
| QQQS · Invesco Exchange-Traded Fund Trust … | — | — | 05 Ağustos 2026 | Günlük |